No Data
No Data
Imugene Limited Reports Progress in Cancer Therapies
Why Are ASX 200 Tech Stocks Getting Slammed on Tuesday?
Imugene Ltd: Half Yearly Report and Accounts
Why GQG, Imugene, Mirvac, and Temple & Webster Shares Are Pushing Higher
Imugene Therapy Achieves Two Complete Responses in Patients With Blood Cancer, Shares Rise Past 8%
Which ASX 200 Healthcare Share Will Pay the Best Dividend Yield in 2025?